Acrylamide-reducing yeast receives international approval

By Gwen Ridler contact

- Last updated on GMT

Renaissance BioScience's acrylamide-reducing yeast has been granted new patent and grant approvals from five countries
Renaissance BioScience's acrylamide-reducing yeast has been granted new patent and grant approvals from five countries

Related tags: Acrylamide, Bakery

A non-GMO acrylamide-reducing yeast (ARY) has received new patent allowances and grants from regulatory authorities in China, Russia, India, Australia and Vietnam.

These five new patent grants and allowances for the ARY, developed by bioengineering company Renaissance BioScience Corp, joined previously issued patents from the US, Japan, Indonesia, Chile and Colombia, with patents pending in multiple additional markets. 

Developed using ‘adaptive evolution engineering techniques’, the ARY – when added during the standard manufacturing processing stage – begins to consume asparagine and reduces the potential for acrylamide formation when the mixture is later cooked above 120°C (248°F). 

Protected use 

Commenting on the newly granted patents, Renaissance BioScience chief executive and chief science officer John Husnik, said: These new patents join those already granted or pending in other major markets around the world, to protect the use of our acrylamide-reducing yeast in many different and important food manufacturing applications.” 

He added: Acrylamide is a carcinogen of global concern—especially for children, who tend to consume more than adults due to their daily diet of many common foods that unfortunately contain this carcinogen (crackers, bread, cookies, cereals and the like).  

Global acceptance ​ 

“We are especially pleased that our acrylamide-reducing yeast is finding acceptance and being commercialized by food manufacturers in markets all around the world with a mandate to reduce the presence of this contaminant in their products.” 

Last year saw scientists from the University of Bristol use genome editing to reduce levels of acrylamide found in baked and toasted wheat-based foods. 

Project leader Professor Nigel Halford said it was the first such trial of genome edited wheat to be carried out in Europe and emphasized it was essential to test the wheat in field trials to see how it performs, not only in terms of asparagine concentration but also yield, protein content and other quality and agronomic traits. 

Related news

Show more

comments

Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.